NCT06759350View on ClinicalTrials.gov

Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

August 1, 2025

Conditions
MenopauseMenopausal WomenSoy Isoflavone EffectQuality of Life
Interventions
DIETARY_SUPPLEMENT

Soy isoflavone supplement

2 capsules containing 10 mg natural tocotrienols, 40 mg soy isoflavonoids, 540 mg calcium, vitamin D IU.

OTHER

Control (placebo) group

2 placebo capsules containing a multivitamin compound.

Trial Locations (1)

11101

Hospital Escuela, Tegucigalpa

All Listed Sponsors
lead

Universidad Nacional Autonoma de Honduras

OTHER

NCT06759350 - Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women | Biotech Hunter | Biotech Hunter